What causes fgfr3 mutation

What Causes FGFR3 Mutations?

Fibroblast growth factor receptor 3 (FGFR3) mutations are genetic alterations that play a significant role in the development of a range of skeletal disorders, collectively known as skeletal dysplasias. These conditions affect bone growth and development, leading to various physical characteristics. Understanding the origins of these mutations is crucial for comprehending the inheritance patterns and the biological mechanisms involved.

Understanding Genetic Mutations

Our bodies are made up of billions of cells, and within each cell is DNA, which contains the instructions for how our bodies grow and function. DNA is organized into genes, and genes are like specific recipes for making proteins. Proteins perform many vital tasks in our bodies. A mutation is a change in the DNA sequence of a gene. These changes can happen for various reasons, and they can affect the protein that the gene makes, or even prevent it from being made at all. Some mutations have no effect, while others can cause diseases or disorders.

The Role of FGFR3

The FGFR3 gene provides instructions for making a protein that is part of the fibroblast growth factor receptor family. These receptors are involved in the development and maintenance of various tissues, particularly during embryonic development. They are crucial for the growth and maturation of bones and the brain. The FGFR3 protein acts as a receptor on the surface of cells, receiving signals from fibroblast growth factors (FGFs) that tell the cell to grow, differentiate, or move. In the context of skeletal development, FGFR3 plays a critical role in regulating the growth of long bones from cartilage.

How FGFR3 Mutations Occur

The vast majority of FGFR3 mutations that cause skeletal dysplasias are classified as de novo mutations. The term de novo (Latin for "new") signifies that the mutation is present for the first time in a family member. This means that neither of the parents carries the mutation in their own cells, and therefore, they cannot pass it on to their child. Instead, the mutation occurs spontaneously:

• During Gamete Formation: The mutation can arise in a sperm cell of the father or an egg cell of the mother just before conception. When this altered sperm or egg cell combines to form an embryo, the resulting individual will have the mutation in all of their cells.
• Early Embryonic Development: Alternatively, the mutation can occur very early in the life of the embryo, shortly after fertilization. If this happens, some cells of the body will carry the mutation, while others might not (a condition known as mosaicism). However, for most clinically significant FGFR3 skeletal dysplasias, the mutation is present in all cells.

Because these mutations are typically de novo, individuals diagnosed with conditions like achondroplasia, hypochondroplasia, or thanatophoric dysplasia usually do not have a family history of the condition. This can sometimes make diagnosis challenging, as there is no prior indication within the family's medical history.

Inheritance Patterns (When Applicable)

While most FGFR3 mutations are de novo, there are rare instances where a mutation might be inherited. If a parent has a mild form of a skeletal dysplasia caused by an FGFR3 mutation, or if they have germline mosaicism (where the mutation is present in some of their sperm or egg cells but not in their other body cells), they could potentially pass the mutation on to their children. In such cases, the inheritance pattern is typically autosomal dominant. This means that only one copy of the altered gene is sufficient to cause the condition. If a parent has an autosomal dominant condition, each child has a 50% chance of inheriting the mutated gene and developing the condition.

Factors Influencing *De Novo* Mutations

The exact trigger for a de novo mutation is often unknown. However, scientific research has identified a correlation between advanced paternal age and an increased risk of de novo mutations in general. Sperm cells undergo continuous division and replication throughout a man's life. With each division, there is a small chance that errors (mutations) can occur in the DNA. Therefore, older fathers may have a slightly higher risk of passing on a sperm with a new mutation compared to younger fathers. While this is a general trend for many genetic conditions, it's important to remember that the vast majority of children born to older fathers do not have genetic disorders.

Impact of FGFR3 Mutations

When a mutation occurs in the FGFR3 gene, it often leads to an overactive receptor protein. This overactivity disrupts the normal process of bone formation, particularly in the growth plates of long bones. Instead of growing at a normal rate, the cartilage in the growth plates ossifies (turns into bone) prematurely or too quickly. This results in bones that are shorter and wider than average, leading to the characteristic features of skeletal dysplasias such as achondroplasia (the most common form, characterized by disproportionately short limbs) and other related conditions.

Conclusion

In summary, FGFR3 mutations are primarily caused by spontaneous genetic changes that occur randomly during reproductive cell formation or very early embryonic development. They are rarely inherited from parents. These de novo mutations lead to an overactive FGFR3 receptor, significantly impacting skeletal development and causing a spectrum of genetic skeletal disorders.